Dual Therapy’s One-Two Punch Knocks Out Drug-Resistant Lung Cancer
UCSF scientists have identified a biological escape hatch that explains the resistance to targeted drug treatment in some lung cancer patients.
University of California San Francisco
Give to UCSFUCSF scientists have identified a biological escape hatch that explains the resistance to targeted drug treatment in some lung cancer patients.
A research team at UCSF has won a five-year award of $14.1 million from the Patient-Centered Outcomes Research Institute to investigate whether a personalized approach to breast cancer screening is as safe and effective as annual mammograms.
A new study of acute lymphoblastic leukemia led by UCSF researchers puts an intriguing new twist on anti-cancer strategies.
UCSF Chancellor and Professor Emeritus J. Michael Bishop, MD, Professor Emeritus Harold Varmus, MD, and Chancellor and Professor Emeritus Susan Desmond-Hellmann, MD, MPH, will be highlighted for their pioneering work on cancer in the Ken Burns-produced PBS documentary series “Cancer: The Emperor of All Maladies,” which airs March 30-April 1, 2015.
A new study of acute lymphoblastic leukemia has revealed that the disease has two distinct subtypes, and provides preliminary evidence that about 13 percent of cases may be successfully treated with targeted drugs.
New research finds a special protein may control the survival of deep, near-dormant cancer cells that allow tumors to regrow even after other cells have been eradicated.
A protein called YAP, which drives the growth of organs during development and regulates their size in adulthood, plays a key role in the emergence of resistance to targeted cancer therapies, according to a new study.
With advances in technology and better understanding of people, the health sciences are constantly pushing toward more effective treatments and cures. The question is, where will we see the next breakthroughs in 2015?
The idea of art as medicine dates back to antiquity, but recently the concept is drawing increasing interest from the medical and science communities.
Two major factors determine whether you get cancer – your genes and what you have been exposed to in the environment, says Allan Balmain, PhD, co-leader of UCSF’s Cancer Genetics Program.
After more than 10 years of planning and construction, UCSF Medical Center at Mission Bay will open Feb. 1, 2015 on UCSF’s world-renowned biomedical research campus.
Nonsmokers sitting in an automobile with a smoker had markers of significantly increased levels of carcinogens, indicating that secondhand smoke in motor vehicles poses a potentially major health risk.
UCSF is unveiling a comprehensive cancer genetic testing program integrated with patients' electronic medical records, a major milestone in bringing precision medicine into everyday practice.
UCSF has unveiled a new cloud-based software platform that significantly advances precision medicine for cancer.
Genetically engineering tumors in mice, a technique that has dominated cancer research for decades, may not replicate important features of cancers caused by exposure to environmental carcinogens, according to a new study led by UCSF scientists.
Physicians at the new UCSF Benioff Children’s Hospital San Francisco are dedicated to cutting-edge research that helps minimize invasive treatment for very sick children.
For the first time, researchers have found that exposure to radioactive iodine is associated with more aggressive forms of thyroid cancer, according to a careful study of nearly 12,000 people in Belarus who were exposed when they were children or adolescents to fallout from the 1986 Chernobyl nuclear power plant accident.
California’s position as a leader in tobacco control is under threat, according to a new report from the UC San Francisco Center for Tobacco Control Research and Education.
An international research collaboration led by UCSF researchers has identified a genetic variant common in Latina women that protects against breast cancer.
A newly discovered population of immune cells in tumors is associated with less severe cancer outcomes in humans, and may have therapeutic potential, according to a new UCSF study.
Juliana's Journey Foundation - established in honor of two-and-a-half-year-old Juliana Peña, who passed away in 2012 from brain cancer - recently gave $15,000 to UCSF's Kate Matthay, MD, to develop treatments for neuroblastoma.
It sounds like science fiction, but it seems that bacteria within us – which outnumber our own cells about 100-fold – may very well be affecting both our cravings and moods to get us to eat what they want, and often are driving us toward obesity.
Osteoporosis drugs known as bisphosphonates may not protect women from breast cancer as had been thought, according to a new study led by researchers at UCSF.
New research partly led by UCSF-affiliated scientists suggests that one in 10 cancer patients would be more accurately diagnosed if their tumors were defined by cellular and molecular criteria rather than by the tissues in which they originated.
UCSF Medical Center is among the nation's premier hospitals for the 13th consecutive year, ranking as the eighth best hospital in the country according to U.S. News & World Report.
Twitter and other social media should be better utilized to convey public health messages, especially to young adults, according to a new analysis by researchers at UC San Francisco.
UCSF scientists have shown that cancer-induced structural changes in a sugary coating ensheathing cells can promote mechanical interactions that fuel tumor growth and metastasis.
The Ras protein is one of the most common and deadly drivers of cancer, yet it has eluded any drug therapies for decades. Scientists are getting close to changing that.
New genomic research led by UCSF scientists reveals that two common gene variants that lead to longer telomeres also significantly increase the risk of developing the deadly brain cancers known as gliomas.